A surface engineering manufacturing business first founded in Bristol and now headquartered in Gloucester, has welcomed a fifth generation of the family which established the company in 1898
James Poeton-Bridgens, son of the current Chairman Anthony and his wife Rowenna, has joined Poeton Industries, bringing a degree in chemical engineering from the University of Bath.
While has spent the last 10 years post-graduation building a successful career in senior sales roles within the technology industry, most recently at Oracle Corporation, James cut his teeth in the industry working in Poeton’s laboratories during his school holidays.
Having joined at the beginning of October, James will now embark on a Group Management Training programme, spending time getting to know the business more thoroughly from the ground level up. He will work across all aspects of the business including sales and productions as well as getting hands on training processing components across the range of treatments available.
Darren Burge, Managing Director of Poeton Industries, commented: “This scheme will give James a sound understanding of what it is that makes Poeton a supplier of choice and will help him develop a fundamental understanding of the broad scope of the services Poeton provide. Ultimately this will enable James to become an effective member of the board, helping to shape the future direction of the business.
“This announcement represents an exciting new chapter in the history of Poeton, especially during these unprecedented times of the Covid19 pandemic and reinforces the family commitment to being a surface treatment supplier of choice.”
Founded in 1898 by Arthur Thomas Poeton, the business has evolved to become a leader in surface treatments, including the development of unique techniques that help engineers and manufacturers to push conventional materials to their limit. James follows George, William and Anthony Poeton into the family business and in helping to shape the continued success and innovation within the surface treatment industry.